186
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland

, , , &
Pages 455-465 | Published online: 01 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Abdisa Ejeta, Tekabe Abdosh, Behailu Hawulte, Adugna Lamessa, Meseret Belete Fite & Gelana Fekadu. (2021) Diabetes Concordant Comorbidities and Associated Factors Among Adult Diabetic Out-Patients at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia: a Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity 14, pages 2281-2289.
Read now
Mark Nuijten, Livia Dainelli, Bahareh Rasouli, Krysmaru Araujo Torres, Moreno Perugini & Agnieszka Marczewska. (2021) A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer’s Perspective. Diabetes, Metabolic Syndrome and Obesity 14, pages 3147-3160.
Read now
Caroline Bähler, Andri Signorell, Eva Blozik & Oliver Reich. (2018) Intensity of treatment in Swiss cancer patients at the end-of-life. Cancer Management and Research 10, pages 481-491.
Read now

Articles from other publishers (20)

Angela Y. Chang, Dana Bryazka & Joseph L. Dieleman. (2023) Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States. PLOS Medicine 20:4, pages e1004205.
Crossref
Vivien Hohberg, Jan-Niklas Kreppke, Jan Kohl, Eleonora Seelig, Lukas Zahner, Fiona Streckmann, Markus Gerber, Daniel König & Oliver Faude. (2022) Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial. BMJ Open 12:6, pages e057948.
Crossref
Yu Fu, Mingsheng Chen & Lei Si. (2022) Multimorbidity and catastrophic health expenditure among patients with diabetes in China: a nationwide population-based study. BMJ Global Health 7:2, pages e007714.
Crossref
Jumpei Sato, Naohiro Mitsutake, Masaru Kitsuregawa, Tomoki Ishikawa & Kazuo Goda. (2022) Predicting demand for long-term care using Japanese healthcare insurance claims data. Environmental Health and Preventive Medicine 27:0, pages 42-42.
Crossref
Inmaculada Guerrero-Fernández de Alba, Valentina Orlando, Valeria M. Monetti, Sara Mucherino, Antonio Gimeno-Miguel, Olga Vaccaro, Maria João Forjaz, Beatriz Poblador Plou, Alexandra Prados-Torres, Gabriele Riccardi & Enrica Menditto. (2020) Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients. Frontiers in Pharmacology 11.
Crossref
Carola A. Huber, Reto Agosti, Markus Näpflin & Eva Blozik. (2019) Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database. Pharmacoepidemiology and Drug Safety 29:3, pages 279-287.
Crossref
Maryam Mohammad Zadeh, Hester Lingsma, Johan W. Neck, Dalibor Vasilic & Anne‐Margreet Dishoeck. (2019) Outcome predictors for wound healing in patients with a diabetic foot ulcer. International Wound Journal 16:6, pages 1339-1346.
Crossref
Juliana L Torres, Silvia L A da Silva, Fabiane R Ferreira, Liliane P S Mendes & Luciana A Machado. (2019) Chronic pain is associated with increased health care use among community-dwelling older adults in Brazil: the Pain in the Elderly (PAINEL) Study. Family Practice 36:5, pages 594-599.
Crossref
Joan Henderson, Stephen Barnett, Abhijeet Ghosh, Allan J Pollack, Adam Hodgkins, Khin Than Win, Graeme C Miller & Andrew Bonney. (2018) Validation of electronic medical data: Identifying diabetes prevalence in general practice. Health Information Management Journal 48:1, pages 3-11.
Crossref
Sandipana Pati & F. G. Schellevis. (2017) Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India). PLOS ONE 12:8, pages e0181661.
Crossref
Caroline Bähler, Alain M. Schoepfer, Stephan R. Vavricka, Beat Brüngger & Oliver Reich. (2017) Chronic comorbidities associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 29:8, pages 916-925.
Crossref
Avi Porath, Naama Fund & Yasmin Maor. (2016) Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study. Diabetes Therapy 8:1, pages 167-176.
Crossref
Carla Sancho-Mestre, David Vivas-Consuelo, Luis Alvis-Estrada, Martin Romero, Ruth Usó-Talamantes & Vicent Caballer-Tarazona. (2016) Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data. BMC Health Services Research 16:1.
Crossref
Kathryn Fisher, Lauren Griffith, Andrea Gruneir, Dilzayn Panjwani, Sima Gandhi, Li (Lisa) Sheng, Amiram Gafni, Patterson Chris, Maureen Markle-Reid & Jenny Ploeg. (2016) Comorbidity and its relationship with health service use and cost in community-living older adults with diabetes: A population-based study in Ontario, Canada. Diabetes Research and Clinical Practice 122, pages 113-123.
Crossref
Wayne Weng, Yuanjie Liang, Edward S. Kimball, Todd Hobbs, Sheldon X. Kong, Brian Sakurada & Jonathan Bouchard. (2016) Decreasing incidence of type 2 diabetes mellitus in the United States, 2007–2012: Epidemiologic findings from a large US claims database. Diabetes Research and Clinical Practice 117, pages 111-118.
Crossref
Wayne Weng, Yuanjie Liang, Edward S. Kimball, Todd Hobbs, Sheldon Kong, Brian Sakurada & Jonathan Bouchard. (2016) Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012. Clinical Therapeutics 38:6, pages 1314-1326.
Crossref
Nannan Gao, Zhongshang Yuan, Xulei Tang, Xiaoming Zhou, Meng Zhao, Lu Liu, Jiadong Ji, Fuzhong Xue, Guang Ning, Jiajun Zhao, Haiqing Zhang & Ling Gao. (2016) Prevalence of CHD-related metabolic comorbidity of diabetes mellitus in Northern Chinese adults: the REACTION study. Journal of Diabetes and its Complications 30:2, pages 199-205.
Crossref
Sejeong ParkSo Young ParkYu Jin KimSoo Min HongSuk ChonSeungjoon OhJeong-taek WooSung-Woon KimYoung Seol KimSang Youl Rhee. (2016) Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal 40:3, pages 240.
Crossref
Hilde D. Luijks, Antoine L.M. Lagro-Janssen & Chris van Weel. (2016) Multimorbidity and the Primary Healthcare Perspective. Journal of Comorbidity 6:2, pages 46-49.
Crossref
A. E. Berezin, A. A. Kremzer, T. A. Samura, T. A. Berezina & P. Kruzliak. (2015) Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. Journal of Endocrinological Investigation 38:8, pages 865-874.
Crossref